Literature DB >> 9452396

Genetic diversity of wild-type measles viruses: implications for global measles elimination programs.

W J Bellini1, P A Rota.   

Abstract

Wild-type measles viruses have been divided into distinct genetic groups according to the nucleotide sequences of their hemagglutinin and nucleoprotein genes. Most genetic groups have worldwide distribution; however, at least two of the groups appear to have a more limited circulation. To monitor the transmission pathways of measles virus, we observed the geographic distribution of genetic groups, as well as changes in them in a particular region over time. We found evidence of interruption of indigenous transmission of measles in the United States after 1993 and identified the sources of imported virus associated with cases and outbreaks after 1993. The pattern of measles genetic groups provided a means to describe measles outbreaks and assess the extent of virus circulation in a given area. We expect that molecular epidemiologic studies will become a powerful tool for evaluating strategies to control, eliminate, and eventually eradicate measles.

Entities:  

Mesh:

Year:  1998        PMID: 9452396      PMCID: PMC2627654          DOI: 10.3201/eid0401.980105

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  17 in total

1.  Molecular epidemiology and changing distribution of genotypes of measles virus field strains in Japan.

Authors:  Y Katayama; K Shibahara; T Kohama; M Homma; H Hotta
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 2.  Measles virus strain variations.

Authors:  B K Rima; J A Earle; K Baczko; P A Rota; W J Bellini
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

3.  Absence of reported measles--United States, November 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-12-10       Impact factor: 17.586

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics.

Authors:  P A Rota; A E Bloom; J A Vanchiere; W J Bellini
Journal:  Virology       Date:  1994-02       Impact factor: 3.616

6.  Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains.

Authors:  J S Rota; Z D Wang; P A Rota; W J Bellini
Journal:  Virus Res       Date:  1994-03       Impact factor: 3.303

7.  Variation in field isolates of measles virus during an 8-year period in Japan.

Authors:  H Sakata; F Kobune; T A Sato; K Tanabayashi; A Yamada; A Sugiura
Journal:  Microbiol Immunol       Date:  1993       Impact factor: 1.955

8.  Temporal and geographical distribution of measles virus genotypes.

Authors:  B K Rima; J A Earle; R P Yeo; L Herlihy; K Baczko; V ter Meulen; J Carabaña; M Caballero; M L Celma; R Fernandez-Muñoz
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

9.  Cloning and characterization of the cDNA encoding the HA protein of a hemagglutination-defective measles virus strain.

Authors:  H Saito; H Sato; M Abe; S Harata; K Amano; T Suto; M Morita
Journal:  Virus Genes       Date:  1994-03       Impact factor: 2.332

10.  Rescue of measles viruses from cloned DNA.

Authors:  F Radecke; P Spielhofer; H Schneider; K Kaelin; M Huber; C Dötsch; G Christiansen; M A Billeter
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

View more
  36 in total

1.  Epitope analysis for influenza vaccine design.

Authors:  Enrique T Muñoz; Michael W Deem
Journal:  Vaccine       Date:  2005-01-19       Impact factor: 3.641

2.  Application of DNA array technology for diagnostic microbiology.

Authors:  S A Booth; M A Drebot; G A Tipples; L K Ng
Journal:  Can J Infect Dis       Date:  2000-11

Review 3.  Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras.

Authors:  Michaela A Riddell; Jennifer S Rota; Paul A Rota
Journal:  Virol J       Date:  2005-11-22       Impact factor: 4.099

4.  Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.

Authors:  J Fayolle; B Verrier; R Buckland; T F Wild
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins.

Authors:  Benjamin O Fulton; David Sachs; Shannon M Beaty; Sohui T Won; Benhur Lee; Peter Palese; Nicholas S Heaton
Journal:  Cell Rep       Date:  2015-05-21       Impact factor: 9.423

Review 6.  Case report and molecular analysis of subacute sclerosing panencephalitis in a South African Child.

Authors:  E Vardas; P M Leary; J Yeats; W Badrodien; S Kreis
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Role of clinicians and public health professionals for measles surveillance in Canada.

Authors:  G A Tipples
Journal:  Paediatr Child Health       Date:  1999-01       Impact factor: 2.253

8.  Measles virus genotyping by nucleotide-specific multiplex PCR.

Authors:  Jacques R Kremer; Fred Fack; Christophe M Olinger; Mick N Mulders; Claude P Muller
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Molecular epidemiology of measles viruses in the United States, 1997-2001.

Authors:  Paul A Rota; Stephanie L Liffick; Jennifer S Rota; Russell S Katz; Susan Redd; Mark Papania; William J Bellini
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

10.  Genetic homogeneity of measles viruses associated with a measles outbreak, São Paulo, Brazil, 1997.

Authors:  Maria I Oliveira; Paul A Rota; Suely P Curti; Cristina A Figueiredo; Ana M S Afonso; Marcia Theobaldo; Luiza T M Souza; Stephanie L Liffick; William J Bellini; Jose C Moraes; Klaus E Stevien; Edison L Durigon
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.